The article discusses sex differences in pharmacokinetics and pharmacodynamics, emphasizing the importance of understanding these differences to ensure safe and effective drug treatment for both men and women. It highlights that males and females respond differently to drug treatment, which can affect therapeutic outcomes. The review covers factors influencing drug absorption, distribution, metabolism, and elimination, including hormonal influences on cytochrome P450 enzymes and transporter proteins. It also addresses the impact of pregnancy, menopause, and the use of oral contraceptives on drug metabolism and excretion. The article notes that women may experience more severe adverse drug events and are more sensitive to drugs, possibly due to differences in drug concentrations, metabolism, or drug interactions. It emphasizes the need for clinical trials to include both sexes and for healthcare providers to consider sex-related differences when prescribing medications. The review also discusses the role of hormonal changes during pregnancy and menopause in altering drug metabolism and excretion, and the importance of understanding these differences for optimal therapeutic outcomes. The article concludes that further research is needed to better understand the mechanisms behind sex differences in pharmacokinetics and pharmacodynamics.The article discusses sex differences in pharmacokinetics and pharmacodynamics, emphasizing the importance of understanding these differences to ensure safe and effective drug treatment for both men and women. It highlights that males and females respond differently to drug treatment, which can affect therapeutic outcomes. The review covers factors influencing drug absorption, distribution, metabolism, and elimination, including hormonal influences on cytochrome P450 enzymes and transporter proteins. It also addresses the impact of pregnancy, menopause, and the use of oral contraceptives on drug metabolism and excretion. The article notes that women may experience more severe adverse drug events and are more sensitive to drugs, possibly due to differences in drug concentrations, metabolism, or drug interactions. It emphasizes the need for clinical trials to include both sexes and for healthcare providers to consider sex-related differences when prescribing medications. The review also discusses the role of hormonal changes during pregnancy and menopause in altering drug metabolism and excretion, and the importance of understanding these differences for optimal therapeutic outcomes. The article concludes that further research is needed to better understand the mechanisms behind sex differences in pharmacokinetics and pharmacodynamics.